Navigation Links
Europe rallies behind nanotechnology to wean world from fossil fuels
Date:10/9/2008

place a large fraction of today's fossil-based electricity generation," said Kasemo. "It also would solve the day/night problem and therefore reduce storage needs because the sun always shines somewhere."

In the immediate future, solid state technologies based on silicon are likely to predominate the production (manufacture) of solar cells, but DSC and other "runners ups" are likely to lower costs in the long term, using cheaper semiconductor materials to produce robust flexible sheets strong enough to resist buffeting from hail for example. Although less efficient than the very best silicon or thin film cells using current technology, their better price/performance has led the European Union to predict that DSCs will be a significant contributor to renewable energy production in Europe by 2020. The DSC was invented by Michael Grtzel, one of the speakers and vice chair at the ESF conference.

The key point to emerge from the ESF conference, though, is that there will be growing choice and competition between emerging nanotechnology-based solar conversion technologies. "I think the important fact is that there is strong competition and that installed solar power is growing very rapidly, albeit from a small base," said Kasemo."This will push prices down and make solar electricity more and more competitive."

Some of the most exciting of these alternatives lie in the field of biomimetics, which involves mimicking processes that have been perfected in biological organisms through eons of evolution. Plants and a class of bacteria, cyanobacteria, have evolved photosynthesis, involving the harvesting of light and the splitting of water into electrons and protons to provide a stream of energy that in turn produces the key molecules of life. Photosynthesis can potentially be harnessed either in genetically-engineered organisms, or completely artificial human-made systems that mimic the processes, to produce carbon-free fuels such as hydrogen. Alternat
'/>"/>

Contact: Professor Bengt Kasemo
kasemo@fy.chalmers.se
46-317-723-370
European Science Foundation
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Significant increase in alien plants in Europe
2. Major European program for the environment under the spotlight in Lille, France
3. Toxoplasmosis found more severe in Brazil compared to Europe
4. Study helps pinpoint genetic variations in European Americans
5. European Science Foundation aims to strengthen regenerative medicine
6. Europe-wide investment in lipid research will help tackle disease, says new report
7. Europe gets together to harness quantum physics
8. Securing the future of Europes biological data resources
9. European light research opens door for optical storage and computing
10. Europe develops new technologies to boost health of livestock
11. European membrane expertise to focus on new treatments for human diseases

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)...LLEY, Calif., Oct. 19 Spectros, de...sing and imaging devices which shed light on life-...signed exclusive distribution deals for both its T...markets covered include Australia, New Zealand, T...iname, Italy, France, Spain, Portugal, Poland, Gre...
(Date:11/4/2009)...., Oct. 21 What,s the cost of savi...idental death resulting from prescription medicati...intentions, however, may be unaware that the lock-...eens from the ticking timebomb of prescription dru...emium-quality medical supplies, has formed an excl...
(Date:11/4/2009)...HILL Scientists at the University of North Caroli...rsity of California, San Francisco have developed ...ew target diseases for existing drugs. , The res...pares how similar the structures of all known drug...-- known as ligands -- of disease targets within t...
Breaking Biology News(10 mins):Spectros Signs New International Distribution Deals 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Study points to new uses, unexpected side effects of already existing drugs 2PediaPals to Market Pediatric Exam Tables and Medical Equipment on Target com 54167 1PediaPals to Market Pediatric Exam Tables and Medical Equipment on Target com 54167 2PediaPals to Market Pediatric Exam Tables and Medical Equipment on Target com 54167 3Video 3A People With Pain Healthcare Providers Sound Off in First Ever Online Talk Show About Pain 54162 1Video 3A People With Pain Healthcare Providers Sound Off in First Ever Online Talk Show About Pain 54162 2Video 3A People With Pain Healthcare Providers Sound Off in First Ever Online Talk Show About Pain 54162 3Video 3A People With Pain Healthcare Providers Sound Off in First Ever Online Talk Show About Pain 54162 4Video 3A People With Pain Healthcare Providers Sound Off in First Ever Online Talk Show About Pain 54162 5BrainScope 28TM 29 Receives FDA Clearance for Portable EEG Device 54157 1BrainScope 28TM 29 Receives FDA Clearance for Portable EEG Device 54157 2BrainScope 28TM 29 Receives FDA Clearance for Portable EEG Device 54157 3
...ew study by researchers from Columbia University,s...the most challenging issues in infant health and p... countries. In these settings, HIV-infected mothe...their infants, they should exclusively breast-feed...fter birth. But according to the study conducted i...
... Pennsylvania State University College of Medicine...fficacy of imiquimod, a clinically important immun...tumor activity, is dependent on the Opioid Growth ...on. This discovery, reported in the August 08 iss...s new insights into a widely used drug that may le...
...- Scientists at Harvard University and the Univers...lution is strongly shaped by genes, efforts to pre...Their study also suggests that the cost of errors ...teins themselves, rather than the loss of function...ng-lived cells, like neurons, and cause neurodegen...
Other Biology News:Early cessation of breastfeeding by HIV+ women in poor countries and child survival 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 3Imiquimod, an immune response modifier, is dependent on the OGF-OGFr signaling pathway 2Various species' genes evolve to minimize protein production errors 2Various species' genes evolve to minimize protein production errors 3
(Date:11/6/2009)...mber 6 EUCODIS Bioscience, a compa...keting enzymes for the,chemical industry announced...nt with Bio Sidus, the leading biopharmaceutical c...gives EUCODIS Bioscience exclusive access - for th...oprietary collection of,psychrophilic bacteria str...
(Date:11/6/2009)...PRNewswire/ -- Intarcia Therapeutics, Inc. deliver...#174; continuous delivery of exenatide) program fo...nual Diabetes Technology Meeting in San Francisco,...prnh/20050301/SFTU126LOGO ) ,, Continuous Sub...s Plasma Glucose, HbA1c and Reduces Weight in a 28...
(Date:11/5/2009)... The endangered black-footed ferre...This rare carnivore feeds on prairie dogs. The p...en entire population die-offs in towns occur. The...ented a ferret breeding program and has been relea...native habitat. Unfortunately, plague can sweep t...
(Date:11/5/2009)...ay, November 5, 2009 at 4:30 p.m. Eastern Time ,...irstCall/ - OncoGenex Pharmaceuticals, Inc. ("Onco...ported unaudited financial results for the third q...d reviewed the Company,s highlights for the third ...results reflect the operations of OncoGenex Techno...
Breaking Biology Technology:EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8
...nference Call To Be Held Tuesday, April 1, 2008 At...ylight Time, HOPKINTON, Mass., March 31 Alseres,...ted consolidated financial,results for the year en...ogo: http://www.newscom.com/cgi-bin/prnh/20070608...linical, regulatory, pipeline and,business accompl...
...rst Quarter 2008 Earnings Conference Call Thursday...m. U.S. EDT, FRAZER, Pa., March 31 Cephalon, In...terly earnings conference call,covering first quar...y 1,2008., May 1, 2008 S... distributed by PRNewswire 4:50 p.m. EDT To pa...
... Fiscal year Revenue Increased 51.9% to $33.2 Mill....3% to $12.8 Million, -- The Company Provides G...K and HAIKOU, Hainan, China, March 31,/Xinhua-PRNe..."China,Pharma") (OTC Bulletin Board: CPHI) which d...nded bio-pharmaceutical products in China, today,a...
Other Biology Technology:Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 2Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 3Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 4Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 5Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 6Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 7Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 8Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 9Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 10China Pharma Holdings, Inc. Announces Record 2007 Year End Results 2China Pharma Holdings, Inc. Announces Record 2007 Year End Results 3China Pharma Holdings, Inc. Announces Record 2007 Year End Results 4China Pharma Holdings, Inc. Announces Record 2007 Year End Results 5China Pharma Holdings, Inc. Announces Record 2007 Year End Results 6China Pharma Holdings, Inc. Announces Record 2007 Year End Results 7China Pharma Holdings, Inc. Announces Record 2007 Year End Results 8China Pharma Holdings, Inc. Announces Record 2007 Year End Results 9China Pharma Holdings, Inc. Announces Record 2007 Year End Results 10China Pharma Holdings, Inc. Announces Record 2007 Year End Results 11
Anti-AANAT Antibody, Unconjugated from CHEMICON
Anti-Rac1 / 2 / 3 Monoclonal Antibody, Unconjugated, Clone L129 from Cell Signaling Technology
Sheep Anti-EBNA 3B Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Mouse C5a Receptor (CD88) Monoclonal Antibody, Unconjugated, Clone 10 / 92 from Cell Sciences
Biology Products: